Monte Rosa Therapeutics, Inc. GLUE Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s book value per share?
- Monte Rosa Therapeutics, Inc. (GLUE) reported book value per share of $5.23 in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s book value per share changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s book value per share increased by 57.5% year-over-year, from $3.32 to $5.23.
- What is the long-term trend for Monte Rosa Therapeutics, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s book value per share has grown at a -38.6% compound annual growth rate (CAGR), from -$32.12 to $2.81.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.